A Preclinical Study Comparing the Activity and Potency of OnabotulinumtoxinA and PrabotulinumtoxinA
David C Rupp, David Canty, Catherine Rhéaume, Birgitte Sondergaard, Celina Niño, Ron S Broide, Amy D Brideau-Andersen Allergan Aesthetics, an AbbVie Company, Irvine, CA, USACorrespondence: David C Rupp, Allergan Aesthetics, an AbbVie Company, 2525 Dupont Drive, Irvine, CA, 92612, USA, Tel +1-714-246...
Saved in:
Main Authors: | Rupp DC (Author), Canty D (Author), Rhéaume C (Author), Sondergaard B (Author), Niño C (Author), Broide RS (Author), Brideau-Andersen AD (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of neurotoxic potency between a novel chinbotulinumtoxinA with onabotulinumtoxinA, incobotulinumtoxinA and lanbotulinumtoxinA in rats
by: Feng Y, et al.
Published: (2017) -
OnabotulinumtoxinA for chronic migraine: a critical appraisal
by: Gooriah R, et al.
Published: (2015) -
New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA
by: Andersson KE
Published: (2013) -
Intralesional cryotherapy with triamcinolone and onabotulinumtoxinA injections for umbilical keloid: A case report
by: Jennifer VH Tran, et al.
Published: (2021) -
A Novel OnabotulinumtoxinA Treatment Technique to Obtain Predictable Outcomes in Eyebrow Position and Shape
by: Angelo-Khattar M
Published: (2020)